Abstract
This review is a brief but comprehensive overview on the multi-target profile of oleocanthal, an extra-virgin olive oil (EVOO) phenol corresponding to the (-)-decarboxymethylligstroside aglycone, speculating about its potential in the prevention and/or treatment of various diseases, such as neurodegeneration, inflammation and cancer.
Keywords: Olive oil, oleocanthal, biological targets, multi-pharmacological effect, cancer, inflammation, neurodegeneration.
Graphical Abstract
Current Bioactive Compounds
Title:Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component
Volume: 12 Issue: 1
Author(s): Agostino Casapullo, Federica Del Gaudio, Angela Capolupo, Chiara Cassiano and Maria Chiara Monti
Affiliation:
Keywords: Olive oil, oleocanthal, biological targets, multi-pharmacological effect, cancer, inflammation, neurodegeneration.
Abstract: This review is a brief but comprehensive overview on the multi-target profile of oleocanthal, an extra-virgin olive oil (EVOO) phenol corresponding to the (-)-decarboxymethylligstroside aglycone, speculating about its potential in the prevention and/or treatment of various diseases, such as neurodegeneration, inflammation and cancer.
Export Options
About this article
Cite this article as:
Casapullo Agostino, Del Gaudio Federica, Capolupo Angela, Cassiano Chiara and Monti Chiara Maria, Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666151231184806
DOI https://dx.doi.org/10.2174/1573407212666151231184806 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Current Pharmaceutical Design Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry Molecular Targets of Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Resveratrol and Its Analogues: Promising Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Novel Classes of Dimer Antitumour Drug Candidates
Current Pharmaceutical Design Anesthetic Considerations for Electroconvulsive Therapy-Especially Hemodynamic and Respiratory Management
Current Psychiatry Reviews Characterization of Adipose-Derived Stem Cells: An Update
Current Stem Cell Research & Therapy All for Statins and Statins for All; An Update
Current Pharmaceutical Design Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Exploring Pharmacological Significance of Chalcone Scaffold: A Review
Current Medicinal Chemistry Pindolol Augmentation of Antidepressant Response
Current Drug Targets Is there an Association Between Periodontitis and Atherosclerosis in Adults? A Systematic Review
Current Vascular Pharmacology Cardiac Consequences of Anti-Inflammatory Drugs in Experimental Models
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence
Current Drug Targets - Cardiovascular & Hematological Disorders Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus
Current Pharmaceutical Design